HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fragrance Ingredient Info Should Be Provided To Consumers - EC Opinion

This article was originally published in The Rose Sheet

Executive Summary

Information regarding fragrance chemicals used in cosmetic products that have the potential to cause allergic reactions should be provided to consumers, the Scientific Committee on Cosmetic Products and Non-Food Products concludes in a recently released final opinion.

You may also be interested in...



Fragrance "Allergic Reaction" Warnings Approved By EU Committee

Allergic reaction warning labels for 26 fragrance ingredients identified as allergens by the EU's Scientific Committee on Cosmetic Products and Non-Food Products were adopted as part of the Seventh Amendment to the Cosmetics Directive by the European Environmental Committee in Brussels March 20.

Fragrance "Allergic Reaction" Warnings Approved By EU Committee

Allergic reaction warning labels for 26 fragrance ingredients identified as allergens by the EU's Scientific Committee on Cosmetic Products and Non-Food Products were adopted as part of the Seventh Amendment to the Cosmetics Directive by the European Environmental Committee in Brussels March 20.

U.S./EU Cosmetic "Memo Of Cooperation" May Expand To Canada, Japan

The U.S./EU cosmetics "memorandum of cooperation" may be expanded to include Japan and Canada to provide the legal structure for information exchange and confidentiality agreements between participants.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel